TC BioPharm (TCBP) announced it has entered into a research planning collaboration with Dr. Carlos Maluquer de Motes for the development of a treatment for Monkeypox.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on TCBP:
- TC Biopharm (Holdings) PLC – ADR trading halted, volatility trading pause
- TC Biopharm (Holdings) PLC – ADR trading resumes
- TC Biopharm announces artificial intelligene initiative with Carnegie Mellon
- TC Biopharm announces first patient completes full dose regimen in ACHIEVE trial
- TC Biopharm intends to launch preclinical study for treatment of Mpox